Dr. Maryanhthu Do, D.O

NPI: 1912917659
Total Payments
$11,013
2024 Payments
$2,413
Companies
59
Transactions
637
Medicare Patients
4,198
Medicare Billing
$586,087

Payment Breakdown by Category

Food & Beverage$10,683 (97.0%)
Other$321.83 (2.9%)
Education$8.44 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $10,683 614 97.0%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $321.83 22 2.9%
Education $8.44 1 0.1%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $979.90 47 $0 (2024)
Biogen, Inc. $824.51 42 $0 (2024)
Novartis Pharmaceuticals Corporation $803.40 55 $0 (2024)
SK Life Science, Inc. $795.79 52 $0 (2024)
UCB, Inc. $615.98 48 $0 (2024)
Lundbeck LLC $494.85 28 $0 (2024)
ACADIA Pharmaceuticals Inc $448.49 28 $0 (2024)
Teva Pharmaceuticals USA, Inc. $443.93 28 $0 (2024)
Acorda Therapeutics, Inc $392.40 26 $0 (2023)
PFIZER INC. $357.39 30 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,413 132 ABBVIE INC. ($412.86)
2023 $2,665 163 AbbVie Inc. ($448.94)
2022 $1,550 93 SK Life Science, Inc. ($370.78)
2021 $1,181 75 Biohaven Pharmaceuticals, Inc. ($157.37)
2020 $692.03 37 Greenwich Biosciences, Inc. ($84.73)
2019 $746.02 38 W. L. Gore & Associates, Inc. ($137.66)
2018 $744.13 42 Acorda Therapeutics, Inc ($168.86)
2017 $1,022 57 Teva Pharmaceuticals USA, Inc. ($178.46)

All Payment Transactions

637 individual payment records from CMS Open Payments — Page 1 of 26

Date Company Product Nature Form Amount Type
12/20/2024 SK Life Science, Inc. Food and Beverage In-kind items and services $34.01 General
12/20/2024 Genentech USA, Inc. Ocrevus (Biological), Ocrevus Zunovo Food and Beverage In-kind items and services $15.84 General
Category: Immunology
12/06/2024 Lundbeck LLC VYEPTI (Biological) Food and Beverage Cash or cash equivalent $10.29 General
Category: NEUROLOGY
12/06/2024 Lundbeck LLC VYEPTI (Biological) Food and Beverage Cash or cash equivalent $2.14 General
Category: NEUROLOGY
12/05/2024 Vanda Pharmaceuticals Inc. PONVORY (Drug) Food and Beverage In-kind items and services $28.26 General
Category: MULTIPLE SCLEROSIS
11/25/2024 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $7.70 General
Category: Neurology
11/23/2024 UCB, Inc. Briviact (Drug) Food and Beverage In-kind items and services $7.87 General
Category: Neurology
11/23/2024 UCB, Inc. Briviact (Drug) Food and Beverage In-kind items and services $5.12 General
Category: Neurology
11/21/2024 Amneal Pharmaceuticals LLC CREXONT (Drug) Food and Beverage In-kind items and services $13.27 General
Category: NEUROLOGY
11/20/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $11.09 General
Category: NEUROSCIENCE
11/19/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $18.26 General
Category: PAIN
11/14/2024 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $20.86 General
Category: Neurology
11/14/2024 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $1.49 General
Category: Neurology
11/13/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $19.82 General
Category: BOTOX THERAPEUTIC
11/13/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $17.43 General
Category: PAIN
10/31/2024 Lundbeck LLC VYEPTI (Biological) Food and Beverage Cash or cash equivalent $12.80 General
Category: NEUROLOGY
10/29/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $17.22 General
Category: NEUROSCIENCE
10/25/2024 Vanda Pharmaceuticals Inc. PONVORY (Drug) Food and Beverage In-kind items and services $28.51 General
Category: MULTIPLE SCLEROSIS
10/24/2024 Vanda Pharmaceuticals Inc. PONVORY (Drug) Food and Beverage In-kind items and services $28.51 General
Category: MULTIPLE SCLEROSIS
10/23/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $20.24 General
Category: NEUROSCIENCE
10/17/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $15.06 General
Category: NEUROSCIENCE
10/17/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $7.06 General
Category: NEUROSCIENCE
10/15/2024 Lundbeck LLC VYEPTI (Biological) Food and Beverage Cash or cash equivalent $17.37 General
Category: NEUROLOGY
10/09/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $18.74 General
Category: NEUROSCIENCE
10/07/2024 Lilly USA, LLC AMYVID (Drug), KISUNLA Food and Beverage In-kind items and services $17.12 General
Category: Neuroscience

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 11 1,173 1,848 $467,236 $154,072
2022 8 1,208 1,907 $510,688 $169,864
2021 9 1,012 1,640 $421,601 $147,023
2020 10 805 1,345 $329,665 $115,129
Total Patients
4,198
Total Services
6,740
Medicare Billing
$586,087
Procedure Codes
50

All Medicare Procedures & Services

50 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 209 572 $125,840 $49,773 39.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 215 367 $99,090 $30,051 30.3%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 210 223 $91,430 $28,343 31.0%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 104 116 $42,920 $13,327 31.1%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 89 89 $40,940 $11,971 29.2%
95816 Measurement of brain wave activity (eeg), awake and drowsy Facility 2023 123 129 $15,480 $5,230 33.8%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2023 29 29 $13,340 $3,753 28.1%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 30 35 $12,950 $3,734 28.8%
95819 Measurement of brain wave activity (eeg), awake and asleep Facility 2023 79 80 $9,680 $3,278 33.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 23 26 $7,020 $1,888 26.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 18 18 $3,420 $1,068 31.2%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 11 16 $2,400 $944.16 39.3%
96372 Injection of drug or substance under skin or into muscle Office 2023 16 70 $2,100 $637.45 30.4%
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg Office 2023 17 78 $626.00 $75.12 12.0%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 236 710 $156,200 $53,983 34.6%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 221 228 $93,600 $33,276 35.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 172 278 $75,060 $23,639 31.5%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 124 169 $62,530 $21,206 33.9%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 108 108 $49,680 $15,166 30.5%
95816 Measurement of brain wave activity (eeg), awake and drowsy Facility 2022 118 121 $14,520 $5,047 34.8%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 35 45 $16,650 $4,734 28.4%
95819 Measurement of brain wave activity (eeg), awake and asleep Facility 2022 106 107 $12,947 $4,560 35.2%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2022 35 35 $16,100 $4,556 28.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 39 49 $13,230 $3,630 27.4%
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg Office 2022 14 57 $171.00 $65.79 38.5%

About Dr. Maryanhthu Do, D.O

Dr. Maryanhthu Do, D.O is a Neurology healthcare provider based in Munster, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912917659.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maryanhthu Do, D.O has received a total of $11,013 in payments from pharmaceutical and medical device companies, with $2,413 received in 2024. These payments were reported across 637 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($10,683).

As a Medicare-enrolled provider, Do has provided services to 4,198 Medicare beneficiaries, totaling 6,740 services with total Medicare billing of $586,087. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.

Practice Information

  • Specialty Neurology
  • Other Specialties Neurology
  • Location Munster, IN
  • Active Since 08/08/2006
  • Last Updated 07/10/2019
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • NPI Number 1912917659

Products in Payments

  • NURTEC ODT (Drug) $634.11
  • Briviact (Drug) $585.07
  • UBRELVY (Drug) $556.02
  • TYSABRI (Biological) $454.50
  • NUPLAZID (Drug) $448.49
  • KESIMPTA (Drug) $447.94
  • VYEPTI (Biological) $385.97
  • VALTOCO (Drug) $311.30
  • GILENYA (Drug) $282.54
  • Aimovig (Biological) $269.29
  • AMPYRA (Drug) $210.98
  • QULIPTA (Drug) $203.30
  • EMGALITY (Drug) $198.61
  • Rebif (Biological) $190.13
  • Epidiolex (Drug) $187.41
  • INBRIJA (Drug) $181.42
  • EPIDIOLEX (Drug) $178.40
  • AVONEX (Biological) $175.12
  • AJOVY (Biological) $169.50
  • LUMRYZ (Drug) $159.10

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology Doctors in Munster